Pioneering Flow Synthesis Manufacturing

The HSCF reactor uniquely handles solid reagents and catalysts in continuous flow — a challenge that defeats conventional flow systems. Proprietary internal geometry prevents clogging even with high solid loadings, enabling reactions like Grignard, Suzuki with heterogeneous catalysts, and slurry-phase transformations.

Immiscible liquid–liquid and gas–liquid–solid triphasic reactions are handled with precision. The reactor's high-shear mixing zone creates stable emulsions and maximises interfacial contact area, dramatically accelerating mass transfer rates compared to batch or standard flow reactors.

Seamless linear scale-up from milligram discovery quantities to kilogram production batches without re-optimisation. The identical flow regime at every scale means process parameters transfer directly, compressing typical scale-up timelines from months to days.

Patent portfolio covers over 30 mainstream reaction classes including nitration, diazotisation, lithiation, hydrogenation, ozonolysis, and photochemistry. Each reaction type has been validated with real pharmaceutical intermediates, providing a ready-to-deploy toolkit for drug synthesis campaigns.

Fully autonomous execution of multi-step synthetic sequences without human intervention between steps. The software orchestration layer schedules reagent additions, monitors reaction progress via inline analytics, and triggers the next step only when conversion criteria are met — eliminating operator variability.

Inline workup modules — liquid–liquid extraction, rotary evaporation, filtration, drying, and recrystallisation — are seamlessly chained after each reaction step. This eliminates manual transfer losses and reduces cycle time by up to 60% compared to traditional batch workup procedures.

Literature procedures can be directly imported and reproduced within hours. The platform's condition-transfer engine maps batch parameters to flow equivalents automatically, enabling rapid feasibility assessment and fast entry into GMP-ready semi-continuous manufacturing.

Operators initiate complex multi-step syntheses with a single command. The platform manages all hardware interlocks, safety checks, and process sequencing autonomously. This democratises access to advanced synthesis — enabling non-specialist teams to run complex chemistry reliably.

A Bayesian optimisation engine trained on PhloSyn's proprietary experimental database recommends the next experiment to run, maximising information gain per experiment. The model incorporates mechanistic priors and molecular descriptors, achieving optimal conditions in 5–15 experiments versus 50–200 in traditional DoE approaches.

High-Throughput Experimentation (HTE) arrays run up to 96 parallel micro-scale reactions simultaneously. Automated liquid handling, inline UV/Vis and LCMS analysis, and direct data ingestion into the AI model create a tight feedback loop that compresses weeks of optimisation into 24–48 hours.

Optimised conditions from HTE micro-scale experiments are automatically translated into HSCF flow parameters via a physics-informed transfer model. This eliminates the traditional 'valley of death' between discovery-scale optimisation and production-scale flow synthesis.

The platform continuously learns from every experiment run across all projects, building a compounding proprietary dataset. Each new synthesis campaign benefits from accumulated process knowledge — improving first-pass success rates over time and creating a durable, defensible competitive moat.